MSA prions exhibit remarkable stability and resistance to inactivation

[1]  S. Prusiner,et al.  Bioassays and Inactivation of Prions. , 2017, Cold Spring Harbor perspectives in biology.

[2]  M. Pourfar,et al.  Deep brain stimulation for Tourette syndrome: a single-center series. , 2017, Journal of neurosurgery.

[3]  M. Okun,et al.  Six-Nine Year Follow-Up of Deep Brain Stimulation for Obsessive-Compulsive Disorder , 2016, PloS one.

[4]  P. McKenna,et al.  Clinical Improvement in a Treatment-Resistant Patient With Schizophrenia Treated With Deep Brain Stimulation , 2016, Biological Psychiatry.

[5]  H. Wille,et al.  Neuroinvasion of α-Synuclein Prionoids after Intraperitoneal and Intraglossal Inoculation , 2016, Journal of Virology.

[6]  H. Budka,et al.  Dura mater is a potential source of Aβ seeds , 2016, Acta Neuropathologica.

[7]  D. Guehl,et al.  Outcome of deep brain stimulation in slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature. , 2016, Parkinsonism & related disorders.

[8]  A. Aguzzi,et al.  Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting. , 2016, Swiss medical weekly.

[9]  B. Meier,et al.  An Efficient Procedure for Removal and Inactivation of Alpha-Synuclein Assemblies from Laboratory Materials , 2015, Journal of Parkinson's disease.

[10]  Sebastian Brandner,et al.  Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy , 2015, Nature.

[11]  D. Geschwind,et al.  Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism , 2015, Proceedings of the National Academy of Sciences.

[12]  T. Südhof,et al.  Propagation of prions causing synucleinopathies in cultured cells , 2015, Proceedings of the National Academy of Sciences.

[13]  D. Dickson,et al.  When DLB, PD, and PSP masquerade as MSA , 2015, Neurology.

[14]  M. Giugliano,et al.  α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.

[15]  G. Wenning,et al.  Multiple-system atrophy. , 2015, The New England journal of medicine.

[16]  S. Prusiner,et al.  Mechanism of Scrapie Prion Precipitation with Phosphotungstate Anions , 2014, ACS chemical biology.

[17]  W. Schulz-Schaeffer,et al.  Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates , 2014, Acta neuropathologica communications.

[18]  K. Nilsson,et al.  Aβ seeds resist inactivation by formaldehyde , 2014, Acta Neuropathologica.

[19]  Jacob I. Ayers,et al.  Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice , 2014, Proceedings of the National Academy of Sciences.

[20]  M. Goedert,et al.  Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice , 2013, Acta Neuropathologica.

[21]  S. Prusiner,et al.  Transmission of multiple system atrophy prions to transgenic mice , 2013, Proceedings of the National Academy of Sciences.

[22]  Masato Hasegawa,et al.  Prion-like spreading of pathological α-synuclein in brain , 2013, Brain : a journal of neurology.

[23]  M. Frye,et al.  Deep brain stimulation for treatment-resistant depression: Efficacy, safety and mechanisms of action , 2012, Neuroscience & Biobehavioral Reviews.

[24]  Frank Baumann,et al.  Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis , 2010, Science.

[25]  E. Callaway,et al.  Deep brain stimulation for obsessive-compulsive disorder and treatment-resistant depression: systematic review , 2010, BMC Research Notes.

[26]  G. Wenning,et al.  Multiple system atrophy: an update , 2009, The Lancet Neurology.

[27]  A. Aguzzi,et al.  Induction of cerebral β-amyloidosis: Intracerebral versus systemic Aβ inoculation , 2009, Proceedings of the National Academy of Sciences.

[28]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[29]  M. T. Pellecchia,et al.  Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG) , 2006, Movement disorders : official journal of the Movement Disorder Society.

[30]  S. Prusiner,et al.  Inactivation of Prions by Acidic Sodium Dodecyl Sulfate , 2006, Journal of Virology.

[31]  K. Roth,et al.  Infectivity of Prion Protein Bound to Stainless Steel Wires: A Model for Testing Decontamination Procedures for Transmissible Spongiform Encephalopathies , 2004, Infection Control & Hospital Epidemiology.

[32]  M. Beekes,et al.  Widespread PrPSc accumulation in muscles of hamsters orally infected with scrapie , 2003, EMBO reports.

[33]  A. Kincaid,et al.  Rapid Prion Neuroinvasion following Tongue Infection , 2003, Journal of Virology.

[34]  C. Mathias,et al.  Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? , 2002, Neurology.

[35]  J. Trojanowski,et al.  Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein , 2002, Neuron.

[36]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[37]  J. Collinge,et al.  Transmission of Scrapie by Steel-surface-bound Prions , 2001, Molecular medicine.

[38]  E. Kuusisto,et al.  Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies , 2001, Neuroreport.

[39]  D. Taylor.  Inactivation of prions by physical and chemical means. , 1999, The Journal of hospital infection.

[40]  F. Cohen,et al.  Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.

[41]  J Q Trojanowski,et al.  Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein , 1998, Annals of neurology.

[42]  Nigel J. Cairns,et al.  Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.

[43]  Hitoshi Takahashi,et al.  α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy , 1998, Neuroscience Letters.

[44]  N. Quinn,et al.  Multiple system atrophy: A review of 203 pathologically proven cases , 1997, Movement disorders : official journal of the Movement Disorder Society.

[45]  D. Gajdusek,et al.  Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[46]  Peter L. Lantos,et al.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) , 1989, Journal of the Neurological Sciences.

[47]  S. Prusiner,et al.  Linkage of prion protein and scrapie incubation time genes , 1986, Cell.

[48]  R. Kimberlin,et al.  Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. , 1986, The Journal of general virology.

[49]  D. Gajdusek,et al.  DANGER OF ACCIDENTAL PERSON-TO-PERSON TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE BY SURGERY , 1977, The Lancet.

[50]  Gordon Ws.  Advances in veterinary research. , 1946 .

[51]  Yvonne S. Eisele,et al.  Formaldehyde-fixed brain tissue from spontaneously ill α-synuclein transgenic mice induces fatal α-synucleinopathy in transgenic hosts , 2014, Acta Neuropathologica.

[52]  Molecular Medicine © 1999 The Picower Institute Press Infectivity of Scrapie Prions Bound to a Stainless , 1999 .